RT @yourICM: #visualabstract: Implementation science initiative increases use of LMWH for VTE prophylaxis, but does not improve clinical or…
RT @yourICM: #visualabstract: Implementation science initiative increases use of LMWH for VTE prophylaxis, but does not improve clinical or…
RT @intensivecare_c: ICU患者へのDVT/PE予防を、未分画ヘパリンから低分子ヘパリンに変えても、DVT/PE発症率、出血率共に変わらなかった、と言う介入前後研究 https://t.co/0aOUOdvnUC https://t.co/0aOUOdvn…
RT @intensivecare_c: ICU患者へのDVT/PE予防を、未分画ヘパリンから低分子ヘパリンに変えても、DVT/PE発症率、出血率共に変わらなかった、と言う介入前後研究 https://t.co/0aOUOdvnUC https://t.co/0aOUOdvn…
RT @intensivecare_c: ICU患者へのDVT/PE予防を、未分画ヘパリンから低分子ヘパリンに変えても、DVT/PE発症率、出血率共に変わらなかった、と言う介入前後研究 https://t.co/0aOUOdvnUC https://t.co/0aOUOdvn…
RT @intensivecare_c: ICU患者へのDVT/PE予防を、未分画ヘパリンから低分子ヘパリンに変えても、DVT/PE発症率、出血率共に変わらなかった、と言う介入前後研究 https://t.co/0aOUOdvnUC https://t.co/0aOUOdvn…
RT @intensivecare_c: ICU患者へのDVT/PE予防を、未分画ヘパリンから低分子ヘパリンに変えても、DVT/PE発症率、出血率共に変わらなかった、と言う介入前後研究 https://t.co/0aOUOdvnUC https://t.co/0aOUOdvn…
RT @intensivecare_c: ICU患者へのDVT/PE予防を、未分画ヘパリンから低分子ヘパリンに変えても、DVT/PE発症率、出血率共に変わらなかった、と言う介入前後研究 https://t.co/0aOUOdvnUC https://t.co/0aOUOdvn…
ICU患者へのDVT/PE予防を、未分画ヘパリンから低分子ヘパリンに変えても、DVT/PE発症率、出血率共に変わらなかった、と言う介入前後研究 https://t.co/0aOUOdvnUC https://t.co/0aOUOdvnUC
RT @yourICM: #visualabstract: Implementation science initiative increases use of LMWH for VTE prophylaxis, but does not improve clinical or…
RT @C3_ResNetwork: Multicomponent initiative increased the use of low molecular weight heparin for VTE prophylaxis, but did not change clin…
RT @yourICM: #visualabstract: Implementation science initiative increases use of LMWH for VTE prophylaxis, but does not improve clinical or…
НМГ ничего не дают. Расходимся https://t.co/b0EWDahKk7
RT @yourICM: #visualabstract: Implementation science initiative increases use of LMWH for VTE prophylaxis, but does not improve clinical or…
RT @yourICM: #visualabstract: Implementation science initiative increases use of LMWH for VTE prophylaxis, but does not improve clinical or…
RT @yourICM: #visualabstract: Implementation science initiative increases use of LMWH for VTE prophylaxis, but does not improve clinical or…
RT @kharasauro: Our study shows #ImplementationScience can expedite practice change. Also, highlights the difference between efficacy & ef…
RT @yourICM: #visualabstract: Implementation science initiative increases use of LMWH for VTE prophylaxis, but does not improve clinical or…
RT @yourICM: #visualabstract: Implementation science initiative increases use of LMWH for VTE prophylaxis, but does not improve clinical or…
RT @yourICM: #visualabstract: Implementation science initiative increases use of LMWH for VTE prophylaxis, but does not improve clinical or…
RT @C3_ResNetwork: Multicomponent initiative increased the use of low molecular weight heparin for VTE prophylaxis, but did not change clin…
RT @yourICM: #visualabstract: Implementation science initiative increases use of LMWH for VTE prophylaxis, but does not improve clinical or…
RT @yourICM: #visualabstract: Implementation science initiative increases use of LMWH for VTE prophylaxis, but does not improve clinical or…
RT @C3_ResNetwork: Multicomponent initiative increased the use of low molecular weight heparin for VTE prophylaxis, but did not change clin…
RT @C3_ResNetwork: Multicomponent initiative increased the use of low molecular weight heparin for VTE prophylaxis, but did not change clin…
RT @C3_ResNetwork: Multicomponent initiative increased the use of low molecular weight heparin for VTE prophylaxis, but did not change clin…
Multicomponent initiative increased the use of low molecular weight heparin for VTE prophylaxis, but did not change clinical or economic outcomes. Important lessons and takeaways from this study! @StelfoxTom @JParsonsLeigh @dan_niven @kmfiest @Chip_Doig @k
RT @kharasauro: Our study shows #ImplementationScience can expedite practice change. Also, highlights the difference between efficacy & ef…
RT @yourICM: #visualabstract: Implementation science initiative increases use of LMWH for VTE prophylaxis, but does not improve clinical or…
RT @kharasauro: Our study shows #ImplementationScience can expedite practice change. Also, highlights the difference between efficacy & ef…
Our study shows #ImplementationScience can expedite practice change. Also, highlights the difference between efficacy & effectiveness - RCTs found LMWH more efficacious than UFH, but we found the effectiveness of LMWH under real-world conditions is un
RT @yourICM: #visualabstract: Implementation science initiative increases use of LMWH for VTE prophylaxis, but does not improve clinical or…
RT @yourICM: #visualabstract: Implementation science initiative increases use of LMWH for VTE prophylaxis, but does not improve clinical or…
#visualabstract: Implementation science initiative increases use of LMWH for VTE prophylaxis, but does not improve clinical or economic outcomes. Free link: https://t.co/knZC6P0sgC @kharasauro @HlmsJ @Dr_Cit @ESICM @ClinMedJournals https://t.co/9u0k6yDZJI
RT @hockeypharmd: A pre-post analysis of attempted replacement of UFH with LMWH in Canadian ICUs did not result in any improved clinical ou…
I think it’s likely for many interventions that real world effectiveness is meaningfully less than efficacy estimates from RCT data
A pre-post analysis of attempted replacement of UFH with LMWH in Canadian ICUs did not result in any improved clinical outcomes or a noticable decrease in HIT Dx (as seen in previous literature) https://t.co/sIz8xwbnn2
Intervention for VTE prophylaxis changed practice but not outcomes https://t.co/uMdMm4sWpu At @NIH, we're interested in #implementation research strategies that transform practices & improve outcomes #Grants #Funding #NIHfunded @NIH_NHLBI @AHRQNews @CD
RT @lasecip: A multicentre controlled pre–post trial of an implementation science intervention to improve venous thromboembolism prophylaxi…
A multicentre controlled pre–post trial of an implementation science intervention to improve venous thromboembolism prophylaxis in critically ill patients https://t.co/OP1sxTrwoB #IntCareMed